Global Neurogenetic Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Neurogenetic Testing market size was valued at USD 490.8 million in 2023 and is forecast to a readjusted size of USD 1034.8 million by 2030 with a CAGR of 11.2% during review period.
Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson's disease, epilepsy, and more.
Global key players of neurogenetic testing include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina, Labcorp, etc. The top five players hold a share over 28%. In terms of product type, Exome Sequencing is the largest segment, occupied for a share of 44%, and in terms of application, Hospitals has a share about 46 percent.
The Global Info Research report includes an overview of the development of the Neurogenetic Testing industry chain, the market status of Hospitals (Exome Sequencing, Whole Genome Sequencing), Specialty Clinics (Exome Sequencing, Whole Genome Sequencing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neurogenetic Testing.
Regionally, the report analyzes the Neurogenetic Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neurogenetic Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Neurogenetic Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neurogenetic Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Exome Sequencing, Whole Genome Sequencing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neurogenetic Testing market.
Regional Analysis: The report involves examining the Neurogenetic Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neurogenetic Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Neurogenetic Testing:
Company Analysis: Report covers individual Neurogenetic Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neurogenetic Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Specialty Clinics).
Technology Analysis: Report covers specific technologies relevant to Neurogenetic Testing. It assesses the current state, advancements, and potential future developments in Neurogenetic Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neurogenetic Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Neurogenetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Neurogenetic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurogenetic Testing, with revenue, gross margin and global market share of Neurogenetic Testing from 2019 to 2024.
Chapter 3, the Neurogenetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Neurogenetic Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurogenetic Testing.
Chapter 13, to describe Neurogenetic Testing research findings and conclusion.
Any defect in one or more genes that affect the nervous system can lead to a neurogenetic disorder. Neurogenetic testing is a test for neurogenetic disorders such as dementia, inherited neuropathies, Parkinson's disease, epilepsy, and more.
Global key players of neurogenetic testing include Quest Diagnostics, Mayo Clinic, GeneDx, Illumina, Labcorp, etc. The top five players hold a share over 28%. In terms of product type, Exome Sequencing is the largest segment, occupied for a share of 44%, and in terms of application, Hospitals has a share about 46 percent.
The Global Info Research report includes an overview of the development of the Neurogenetic Testing industry chain, the market status of Hospitals (Exome Sequencing, Whole Genome Sequencing), Specialty Clinics (Exome Sequencing, Whole Genome Sequencing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neurogenetic Testing.
Regionally, the report analyzes the Neurogenetic Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neurogenetic Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Neurogenetic Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neurogenetic Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Exome Sequencing, Whole Genome Sequencing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neurogenetic Testing market.
Regional Analysis: The report involves examining the Neurogenetic Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neurogenetic Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Neurogenetic Testing:
Company Analysis: Report covers individual Neurogenetic Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neurogenetic Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Specialty Clinics).
Technology Analysis: Report covers specific technologies relevant to Neurogenetic Testing. It assesses the current state, advancements, and potential future developments in Neurogenetic Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neurogenetic Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Neurogenetic Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Exome Sequencing
- Whole Genome Sequencing
- RNA Sequencing
- General DNA Testing
- Hospitals
- Specialty Clinics
- Research Institutes
- Diagnostics Laboratories
- Quest Diagnostics
- Mayo Clinic
- GeneDx
- Illumina
- Labcorp
- Invitae
- MedGenome Labs
- Connecticut Children’s
- CENTOGENE
- Victorian Clinical Genetics Services
- PacBio
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Neurogenetic Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Neurogenetic Testing, with revenue, gross margin and global market share of Neurogenetic Testing from 2019 to 2024.
Chapter 3, the Neurogenetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Neurogenetic Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurogenetic Testing.
Chapter 13, to describe Neurogenetic Testing research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Neurogenetic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neurogenetic Testing by Type
1.3.1 Overview: Global Neurogenetic Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Neurogenetic Testing Consumption Value Market Share by Type in 2023
1.3.3 Exome Sequencing
1.3.4 Whole Genome Sequencing
1.3.5 RNA Sequencing
1.3.6 General DNA Testing
1.4 Global Neurogenetic Testing Market by Application
1.4.1 Overview: Global Neurogenetic Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Research Institutes
1.4.5 Diagnostics Laboratories
1.5 Global Neurogenetic Testing Market Size & Forecast
1.6 Global Neurogenetic Testing Market Size and Forecast by Region
1.6.1 Global Neurogenetic Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Neurogenetic Testing Market Size by Region, (2019-2030)
1.6.3 North America Neurogenetic Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Neurogenetic Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Neurogenetic Testing Market Size and Prospect (2019-2030)
1.6.6 South America Neurogenetic Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Neurogenetic Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Quest Diagnostics
2.1.1 Quest Diagnostics Details
2.1.2 Quest Diagnostics Major Business
2.1.3 Quest Diagnostics Neurogenetic Testing Product and Solutions
2.1.4 Quest Diagnostics Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Quest Diagnostics Recent Developments and Future Plans
2.2 Mayo Clinic
2.2.1 Mayo Clinic Details
2.2.2 Mayo Clinic Major Business
2.2.3 Mayo Clinic Neurogenetic Testing Product and Solutions
2.2.4 Mayo Clinic Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Mayo Clinic Recent Developments and Future Plans
2.3 GeneDx
2.3.1 GeneDx Details
2.3.2 GeneDx Major Business
2.3.3 GeneDx Neurogenetic Testing Product and Solutions
2.3.4 GeneDx Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GeneDx Recent Developments and Future Plans
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business
2.4.3 Illumina Neurogenetic Testing Product and Solutions
2.4.4 Illumina Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Illumina Recent Developments and Future Plans
2.5 Labcorp
2.5.1 Labcorp Details
2.5.2 Labcorp Major Business
2.5.3 Labcorp Neurogenetic Testing Product and Solutions
2.5.4 Labcorp Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Labcorp Recent Developments and Future Plans
2.6 Invitae
2.6.1 Invitae Details
2.6.2 Invitae Major Business
2.6.3 Invitae Neurogenetic Testing Product and Solutions
2.6.4 Invitae Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Invitae Recent Developments and Future Plans
2.7 MedGenome Labs
2.7.1 MedGenome Labs Details
2.7.2 MedGenome Labs Major Business
2.7.3 MedGenome Labs Neurogenetic Testing Product and Solutions
2.7.4 MedGenome Labs Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 MedGenome Labs Recent Developments and Future Plans
2.8 Connecticut Children’s
2.8.1 Connecticut Children’s Details
2.8.2 Connecticut Children’s Major Business
2.8.3 Connecticut Children’s Neurogenetic Testing Product and Solutions
2.8.4 Connecticut Children’s Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Connecticut Children’s Recent Developments and Future Plans
2.9 CENTOGENE
2.9.1 CENTOGENE Details
2.9.2 CENTOGENE Major Business
2.9.3 CENTOGENE Neurogenetic Testing Product and Solutions
2.9.4 CENTOGENE Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 CENTOGENE Recent Developments and Future Plans
2.10 Victorian Clinical Genetics Services
2.10.1 Victorian Clinical Genetics Services Details
2.10.2 Victorian Clinical Genetics Services Major Business
2.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Product and Solutions
2.10.4 Victorian Clinical Genetics Services Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Victorian Clinical Genetics Services Recent Developments and Future Plans
2.11 PacBio
2.11.1 PacBio Details
2.11.2 PacBio Major Business
2.11.3 PacBio Neurogenetic Testing Product and Solutions
2.11.4 PacBio Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 PacBio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neurogenetic Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Neurogenetic Testing by Company Revenue
3.2.2 Top 3 Neurogenetic Testing Players Market Share in 2023
3.2.3 Top 6 Neurogenetic Testing Players Market Share in 2023
3.3 Neurogenetic Testing Market: Overall Company Footprint Analysis
3.3.1 Neurogenetic Testing Market: Region Footprint
3.3.2 Neurogenetic Testing Market: Company Product Type Footprint
3.3.3 Neurogenetic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neurogenetic Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Neurogenetic Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neurogenetic Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Neurogenetic Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Neurogenetic Testing Consumption Value by Type (2019-2030)
6.2 North America Neurogenetic Testing Consumption Value by Application (2019-2030)
6.3 North America Neurogenetic Testing Market Size by Country
6.3.1 North America Neurogenetic Testing Consumption Value by Country (2019-2030)
6.3.2 United States Neurogenetic Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Neurogenetic Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Neurogenetic Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Neurogenetic Testing Consumption Value by Type (2019-2030)
7.2 Europe Neurogenetic Testing Consumption Value by Application (2019-2030)
7.3 Europe Neurogenetic Testing Market Size by Country
7.3.1 Europe Neurogenetic Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Neurogenetic Testing Market Size and Forecast (2019-2030)
7.3.3 France Neurogenetic Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Neurogenetic Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Neurogenetic Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Neurogenetic Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neurogenetic Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Neurogenetic Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Neurogenetic Testing Market Size by Region
8.3.1 Asia-Pacific Neurogenetic Testing Consumption Value by Region (2019-2030)
8.3.2 China Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.5 India Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Neurogenetic Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Neurogenetic Testing Consumption Value by Type (2019-2030)
9.2 South America Neurogenetic Testing Consumption Value by Application (2019-2030)
9.3 South America Neurogenetic Testing Market Size by Country
9.3.1 South America Neurogenetic Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Neurogenetic Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Neurogenetic Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neurogenetic Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Neurogenetic Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Neurogenetic Testing Market Size by Country
10.3.1 Middle East & Africa Neurogenetic Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Neurogenetic Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Neurogenetic Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Neurogenetic Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Neurogenetic Testing Market Drivers
11.2 Neurogenetic Testing Market Restraints
11.3 Neurogenetic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Neurogenetic Testing Industry Chain
12.2 Neurogenetic Testing Upstream Analysis
12.3 Neurogenetic Testing Midstream Analysis
12.4 Neurogenetic Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Neurogenetic Testing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Neurogenetic Testing by Type
1.3.1 Overview: Global Neurogenetic Testing Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Neurogenetic Testing Consumption Value Market Share by Type in 2023
1.3.3 Exome Sequencing
1.3.4 Whole Genome Sequencing
1.3.5 RNA Sequencing
1.3.6 General DNA Testing
1.4 Global Neurogenetic Testing Market by Application
1.4.1 Overview: Global Neurogenetic Testing Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Specialty Clinics
1.4.4 Research Institutes
1.4.5 Diagnostics Laboratories
1.5 Global Neurogenetic Testing Market Size & Forecast
1.6 Global Neurogenetic Testing Market Size and Forecast by Region
1.6.1 Global Neurogenetic Testing Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Neurogenetic Testing Market Size by Region, (2019-2030)
1.6.3 North America Neurogenetic Testing Market Size and Prospect (2019-2030)
1.6.4 Europe Neurogenetic Testing Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Neurogenetic Testing Market Size and Prospect (2019-2030)
1.6.6 South America Neurogenetic Testing Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Neurogenetic Testing Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Quest Diagnostics
2.1.1 Quest Diagnostics Details
2.1.2 Quest Diagnostics Major Business
2.1.3 Quest Diagnostics Neurogenetic Testing Product and Solutions
2.1.4 Quest Diagnostics Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Quest Diagnostics Recent Developments and Future Plans
2.2 Mayo Clinic
2.2.1 Mayo Clinic Details
2.2.2 Mayo Clinic Major Business
2.2.3 Mayo Clinic Neurogenetic Testing Product and Solutions
2.2.4 Mayo Clinic Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Mayo Clinic Recent Developments and Future Plans
2.3 GeneDx
2.3.1 GeneDx Details
2.3.2 GeneDx Major Business
2.3.3 GeneDx Neurogenetic Testing Product and Solutions
2.3.4 GeneDx Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 GeneDx Recent Developments and Future Plans
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business
2.4.3 Illumina Neurogenetic Testing Product and Solutions
2.4.4 Illumina Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Illumina Recent Developments and Future Plans
2.5 Labcorp
2.5.1 Labcorp Details
2.5.2 Labcorp Major Business
2.5.3 Labcorp Neurogenetic Testing Product and Solutions
2.5.4 Labcorp Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Labcorp Recent Developments and Future Plans
2.6 Invitae
2.6.1 Invitae Details
2.6.2 Invitae Major Business
2.6.3 Invitae Neurogenetic Testing Product and Solutions
2.6.4 Invitae Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Invitae Recent Developments and Future Plans
2.7 MedGenome Labs
2.7.1 MedGenome Labs Details
2.7.2 MedGenome Labs Major Business
2.7.3 MedGenome Labs Neurogenetic Testing Product and Solutions
2.7.4 MedGenome Labs Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 MedGenome Labs Recent Developments and Future Plans
2.8 Connecticut Children’s
2.8.1 Connecticut Children’s Details
2.8.2 Connecticut Children’s Major Business
2.8.3 Connecticut Children’s Neurogenetic Testing Product and Solutions
2.8.4 Connecticut Children’s Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Connecticut Children’s Recent Developments and Future Plans
2.9 CENTOGENE
2.9.1 CENTOGENE Details
2.9.2 CENTOGENE Major Business
2.9.3 CENTOGENE Neurogenetic Testing Product and Solutions
2.9.4 CENTOGENE Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 CENTOGENE Recent Developments and Future Plans
2.10 Victorian Clinical Genetics Services
2.10.1 Victorian Clinical Genetics Services Details
2.10.2 Victorian Clinical Genetics Services Major Business
2.10.3 Victorian Clinical Genetics Services Neurogenetic Testing Product and Solutions
2.10.4 Victorian Clinical Genetics Services Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Victorian Clinical Genetics Services Recent Developments and Future Plans
2.11 PacBio
2.11.1 PacBio Details
2.11.2 PacBio Major Business
2.11.3 PacBio Neurogenetic Testing Product and Solutions
2.11.4 PacBio Neurogenetic Testing Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 PacBio Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Neurogenetic Testing Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Neurogenetic Testing by Company Revenue
3.2.2 Top 3 Neurogenetic Testing Players Market Share in 2023
3.2.3 Top 6 Neurogenetic Testing Players Market Share in 2023
3.3 Neurogenetic Testing Market: Overall Company Footprint Analysis
3.3.1 Neurogenetic Testing Market: Region Footprint
3.3.2 Neurogenetic Testing Market: Company Product Type Footprint
3.3.3 Neurogenetic Testing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Neurogenetic Testing Consumption Value and Market Share by Type (2019-2024)
4.2 Global Neurogenetic Testing Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Neurogenetic Testing Consumption Value Market Share by Application (2019-2024)
5.2 Global Neurogenetic Testing Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Neurogenetic Testing Consumption Value by Type (2019-2030)
6.2 North America Neurogenetic Testing Consumption Value by Application (2019-2030)
6.3 North America Neurogenetic Testing Market Size by Country
6.3.1 North America Neurogenetic Testing Consumption Value by Country (2019-2030)
6.3.2 United States Neurogenetic Testing Market Size and Forecast (2019-2030)
6.3.3 Canada Neurogenetic Testing Market Size and Forecast (2019-2030)
6.3.4 Mexico Neurogenetic Testing Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Neurogenetic Testing Consumption Value by Type (2019-2030)
7.2 Europe Neurogenetic Testing Consumption Value by Application (2019-2030)
7.3 Europe Neurogenetic Testing Market Size by Country
7.3.1 Europe Neurogenetic Testing Consumption Value by Country (2019-2030)
7.3.2 Germany Neurogenetic Testing Market Size and Forecast (2019-2030)
7.3.3 France Neurogenetic Testing Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Neurogenetic Testing Market Size and Forecast (2019-2030)
7.3.5 Russia Neurogenetic Testing Market Size and Forecast (2019-2030)
7.3.6 Italy Neurogenetic Testing Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Neurogenetic Testing Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Neurogenetic Testing Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Neurogenetic Testing Market Size by Region
8.3.1 Asia-Pacific Neurogenetic Testing Consumption Value by Region (2019-2030)
8.3.2 China Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.3 Japan Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.4 South Korea Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.5 India Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Neurogenetic Testing Market Size and Forecast (2019-2030)
8.3.7 Australia Neurogenetic Testing Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Neurogenetic Testing Consumption Value by Type (2019-2030)
9.2 South America Neurogenetic Testing Consumption Value by Application (2019-2030)
9.3 South America Neurogenetic Testing Market Size by Country
9.3.1 South America Neurogenetic Testing Consumption Value by Country (2019-2030)
9.3.2 Brazil Neurogenetic Testing Market Size and Forecast (2019-2030)
9.3.3 Argentina Neurogenetic Testing Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Neurogenetic Testing Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Neurogenetic Testing Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Neurogenetic Testing Market Size by Country
10.3.1 Middle East & Africa Neurogenetic Testing Consumption Value by Country (2019-2030)
10.3.2 Turkey Neurogenetic Testing Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Neurogenetic Testing Market Size and Forecast (2019-2030)
10.3.4 UAE Neurogenetic Testing Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Neurogenetic Testing Market Drivers
11.2 Neurogenetic Testing Market Restraints
11.3 Neurogenetic Testing Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Neurogenetic Testing Industry Chain
12.2 Neurogenetic Testing Upstream Analysis
12.3 Neurogenetic Testing Midstream Analysis
12.4 Neurogenetic Testing Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Neurogenetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Neurogenetic Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Neurogenetic Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Neurogenetic Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 6. Quest Diagnostics Major Business
Table 7. Quest Diagnostics Neurogenetic Testing Product and Solutions
Table 8. Quest Diagnostics Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Quest Diagnostics Recent Developments and Future Plans
Table 10. Mayo Clinic Company Information, Head Office, and Major Competitors
Table 11. Mayo Clinic Major Business
Table 12. Mayo Clinic Neurogenetic Testing Product and Solutions
Table 13. Mayo Clinic Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Mayo Clinic Recent Developments and Future Plans
Table 15. GeneDx Company Information, Head Office, and Major Competitors
Table 16. GeneDx Major Business
Table 17. GeneDx Neurogenetic Testing Product and Solutions
Table 18. GeneDx Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GeneDx Recent Developments and Future Plans
Table 20. Illumina Company Information, Head Office, and Major Competitors
Table 21. Illumina Major Business
Table 22. Illumina Neurogenetic Testing Product and Solutions
Table 23. Illumina Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Illumina Recent Developments and Future Plans
Table 25. Labcorp Company Information, Head Office, and Major Competitors
Table 26. Labcorp Major Business
Table 27. Labcorp Neurogenetic Testing Product and Solutions
Table 28. Labcorp Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Labcorp Recent Developments and Future Plans
Table 30. Invitae Company Information, Head Office, and Major Competitors
Table 31. Invitae Major Business
Table 32. Invitae Neurogenetic Testing Product and Solutions
Table 33. Invitae Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Invitae Recent Developments and Future Plans
Table 35. MedGenome Labs Company Information, Head Office, and Major Competitors
Table 36. MedGenome Labs Major Business
Table 37. MedGenome Labs Neurogenetic Testing Product and Solutions
Table 38. MedGenome Labs Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. MedGenome Labs Recent Developments and Future Plans
Table 40. Connecticut Children’s Company Information, Head Office, and Major Competitors
Table 41. Connecticut Children’s Major Business
Table 42. Connecticut Children’s Neurogenetic Testing Product and Solutions
Table 43. Connecticut Children’s Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Connecticut Children’s Recent Developments and Future Plans
Table 45. CENTOGENE Company Information, Head Office, and Major Competitors
Table 46. CENTOGENE Major Business
Table 47. CENTOGENE Neurogenetic Testing Product and Solutions
Table 48. CENTOGENE Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. CENTOGENE Recent Developments and Future Plans
Table 50. Victorian Clinical Genetics Services Company Information, Head Office, and Major Competitors
Table 51. Victorian Clinical Genetics Services Major Business
Table 52. Victorian Clinical Genetics Services Neurogenetic Testing Product and Solutions
Table 53. Victorian Clinical Genetics Services Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Victorian Clinical Genetics Services Recent Developments and Future Plans
Table 55. PacBio Company Information, Head Office, and Major Competitors
Table 56. PacBio Major Business
Table 57. PacBio Neurogenetic Testing Product and Solutions
Table 58. PacBio Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. PacBio Recent Developments and Future Plans
Table 60. Global Neurogenetic Testing Revenue (USD Million) by Players (2019-2024)
Table 61. Global Neurogenetic Testing Revenue Share by Players (2019-2024)
Table 62. Breakdown of Neurogenetic Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Neurogenetic Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Neurogenetic Testing Players
Table 65. Neurogenetic Testing Market: Company Product Type Footprint
Table 66. Neurogenetic Testing Market: Company Product Application Footprint
Table 67. Neurogenetic Testing New Market Entrants and Barriers to Market Entry
Table 68. Neurogenetic Testing Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Neurogenetic Testing Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Neurogenetic Testing Consumption Value Share by Type (2019-2024)
Table 71. Global Neurogenetic Testing Consumption Value Forecast by Type (2025-2030)
Table 72. Global Neurogenetic Testing Consumption Value by Application (2019-2024)
Table 73. Global Neurogenetic Testing Consumption Value Forecast by Application (2025-2030)
Table 74. North America Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Neurogenetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Neurogenetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Neurogenetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Neurogenetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Neurogenetic Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Neurogenetic Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Neurogenetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Neurogenetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Neurogenetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Neurogenetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Neurogenetic Testing Raw Material
Table 105. Key Suppliers of Neurogenetic Testing Raw Materials
Table 1. Global Neurogenetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Neurogenetic Testing Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Neurogenetic Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Neurogenetic Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 6. Quest Diagnostics Major Business
Table 7. Quest Diagnostics Neurogenetic Testing Product and Solutions
Table 8. Quest Diagnostics Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Quest Diagnostics Recent Developments and Future Plans
Table 10. Mayo Clinic Company Information, Head Office, and Major Competitors
Table 11. Mayo Clinic Major Business
Table 12. Mayo Clinic Neurogenetic Testing Product and Solutions
Table 13. Mayo Clinic Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Mayo Clinic Recent Developments and Future Plans
Table 15. GeneDx Company Information, Head Office, and Major Competitors
Table 16. GeneDx Major Business
Table 17. GeneDx Neurogenetic Testing Product and Solutions
Table 18. GeneDx Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. GeneDx Recent Developments and Future Plans
Table 20. Illumina Company Information, Head Office, and Major Competitors
Table 21. Illumina Major Business
Table 22. Illumina Neurogenetic Testing Product and Solutions
Table 23. Illumina Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Illumina Recent Developments and Future Plans
Table 25. Labcorp Company Information, Head Office, and Major Competitors
Table 26. Labcorp Major Business
Table 27. Labcorp Neurogenetic Testing Product and Solutions
Table 28. Labcorp Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Labcorp Recent Developments and Future Plans
Table 30. Invitae Company Information, Head Office, and Major Competitors
Table 31. Invitae Major Business
Table 32. Invitae Neurogenetic Testing Product and Solutions
Table 33. Invitae Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Invitae Recent Developments and Future Plans
Table 35. MedGenome Labs Company Information, Head Office, and Major Competitors
Table 36. MedGenome Labs Major Business
Table 37. MedGenome Labs Neurogenetic Testing Product and Solutions
Table 38. MedGenome Labs Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. MedGenome Labs Recent Developments and Future Plans
Table 40. Connecticut Children’s Company Information, Head Office, and Major Competitors
Table 41. Connecticut Children’s Major Business
Table 42. Connecticut Children’s Neurogenetic Testing Product and Solutions
Table 43. Connecticut Children’s Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Connecticut Children’s Recent Developments and Future Plans
Table 45. CENTOGENE Company Information, Head Office, and Major Competitors
Table 46. CENTOGENE Major Business
Table 47. CENTOGENE Neurogenetic Testing Product and Solutions
Table 48. CENTOGENE Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. CENTOGENE Recent Developments and Future Plans
Table 50. Victorian Clinical Genetics Services Company Information, Head Office, and Major Competitors
Table 51. Victorian Clinical Genetics Services Major Business
Table 52. Victorian Clinical Genetics Services Neurogenetic Testing Product and Solutions
Table 53. Victorian Clinical Genetics Services Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Victorian Clinical Genetics Services Recent Developments and Future Plans
Table 55. PacBio Company Information, Head Office, and Major Competitors
Table 56. PacBio Major Business
Table 57. PacBio Neurogenetic Testing Product and Solutions
Table 58. PacBio Neurogenetic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. PacBio Recent Developments and Future Plans
Table 60. Global Neurogenetic Testing Revenue (USD Million) by Players (2019-2024)
Table 61. Global Neurogenetic Testing Revenue Share by Players (2019-2024)
Table 62. Breakdown of Neurogenetic Testing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in Neurogenetic Testing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key Neurogenetic Testing Players
Table 65. Neurogenetic Testing Market: Company Product Type Footprint
Table 66. Neurogenetic Testing Market: Company Product Application Footprint
Table 67. Neurogenetic Testing New Market Entrants and Barriers to Market Entry
Table 68. Neurogenetic Testing Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global Neurogenetic Testing Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global Neurogenetic Testing Consumption Value Share by Type (2019-2024)
Table 71. Global Neurogenetic Testing Consumption Value Forecast by Type (2025-2030)
Table 72. Global Neurogenetic Testing Consumption Value by Application (2019-2024)
Table 73. Global Neurogenetic Testing Consumption Value Forecast by Application (2025-2030)
Table 74. North America Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America Neurogenetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America Neurogenetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe Neurogenetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe Neurogenetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific Neurogenetic Testing Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific Neurogenetic Testing Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America Neurogenetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America Neurogenetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa Neurogenetic Testing Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa Neurogenetic Testing Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa Neurogenetic Testing Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa Neurogenetic Testing Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa Neurogenetic Testing Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa Neurogenetic Testing Consumption Value by Country (2025-2030) & (USD Million)
Table 104. Neurogenetic Testing Raw Material
Table 105. Key Suppliers of Neurogenetic Testing Raw Materials
LIST OF FIGURES
Figure 1. Neurogenetic Testing Picture
Figure 2. Global Neurogenetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Neurogenetic Testing Consumption Value Market Share by Type in 2023
Figure 4. Exome Sequencing
Figure 5. Whole Genome Sequencing
Figure 6. RNA Sequencing
Figure 7. General DNA Testing
Figure 8. Global Neurogenetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Neurogenetic Testing Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Specialty Clinics Picture
Figure 12. Research Institutes Picture
Figure 13. Diagnostics Laboratories Picture
Figure 14. Global Neurogenetic Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Neurogenetic Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Neurogenetic Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Neurogenetic Testing Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Neurogenetic Testing Consumption Value Market Share by Region in 2023
Figure 19. North America Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Neurogenetic Testing Revenue Share by Players in 2023
Figure 25. Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Neurogenetic Testing Market Share in 2023
Figure 27. Global Top 6 Players Neurogenetic Testing Market Share in 2023
Figure 28. Global Neurogenetic Testing Consumption Value Share by Type (2019-2024)
Figure 29. Global Neurogenetic Testing Market Share Forecast by Type (2025-2030)
Figure 30. Global Neurogenetic Testing Consumption Value Share by Application (2019-2024)
Figure 31. Global Neurogenetic Testing Market Share Forecast by Application (2025-2030)
Figure 32. North America Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Neurogenetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Neurogenetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. France Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Neurogenetic Testing Consumption Value Market Share by Region (2019-2030)
Figure 49. China Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. India Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Neurogenetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Neurogenetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. Neurogenetic Testing Market Drivers
Figure 67. Neurogenetic Testing Market Restraints
Figure 68. Neurogenetic Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Neurogenetic Testing in 2023
Figure 71. Manufacturing Process Analysis of Neurogenetic Testing
Figure 72. Neurogenetic Testing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Neurogenetic Testing Picture
Figure 2. Global Neurogenetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Neurogenetic Testing Consumption Value Market Share by Type in 2023
Figure 4. Exome Sequencing
Figure 5. Whole Genome Sequencing
Figure 6. RNA Sequencing
Figure 7. General DNA Testing
Figure 8. Global Neurogenetic Testing Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 9. Neurogenetic Testing Consumption Value Market Share by Application in 2023
Figure 10. Hospitals Picture
Figure 11. Specialty Clinics Picture
Figure 12. Research Institutes Picture
Figure 13. Diagnostics Laboratories Picture
Figure 14. Global Neurogenetic Testing Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Neurogenetic Testing Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Market Neurogenetic Testing Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 17. Global Neurogenetic Testing Consumption Value Market Share by Region (2019-2030)
Figure 18. Global Neurogenetic Testing Consumption Value Market Share by Region in 2023
Figure 19. North America Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 20. Europe Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 21. Asia-Pacific Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 22. South America Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 23. Middle East and Africa Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 24. Global Neurogenetic Testing Revenue Share by Players in 2023
Figure 25. Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 26. Global Top 3 Players Neurogenetic Testing Market Share in 2023
Figure 27. Global Top 6 Players Neurogenetic Testing Market Share in 2023
Figure 28. Global Neurogenetic Testing Consumption Value Share by Type (2019-2024)
Figure 29. Global Neurogenetic Testing Market Share Forecast by Type (2025-2030)
Figure 30. Global Neurogenetic Testing Consumption Value Share by Application (2019-2024)
Figure 31. Global Neurogenetic Testing Market Share Forecast by Application (2025-2030)
Figure 32. North America Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 33. North America Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 34. North America Neurogenetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 35. United States Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 36. Canada Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 37. Mexico Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 38. Europe Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 39. Europe Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 40. Europe Neurogenetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 41. Germany Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 42. France Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 43. United Kingdom Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 44. Russia Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 45. Italy Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 46. Asia-Pacific Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 47. Asia-Pacific Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 48. Asia-Pacific Neurogenetic Testing Consumption Value Market Share by Region (2019-2030)
Figure 49. China Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 50. Japan Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 51. South Korea Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 52. India Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 53. Southeast Asia Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 54. Australia Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 55. South America Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 56. South America Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 57. South America Neurogenetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 58. Brazil Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 59. Argentina Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 60. Middle East and Africa Neurogenetic Testing Consumption Value Market Share by Type (2019-2030)
Figure 61. Middle East and Africa Neurogenetic Testing Consumption Value Market Share by Application (2019-2030)
Figure 62. Middle East and Africa Neurogenetic Testing Consumption Value Market Share by Country (2019-2030)
Figure 63. Turkey Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 64. Saudi Arabia Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 65. UAE Neurogenetic Testing Consumption Value (2019-2030) & (USD Million)
Figure 66. Neurogenetic Testing Market Drivers
Figure 67. Neurogenetic Testing Market Restraints
Figure 68. Neurogenetic Testing Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Neurogenetic Testing in 2023
Figure 71. Manufacturing Process Analysis of Neurogenetic Testing
Figure 72. Neurogenetic Testing Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
